Human CAA-derived leukemia inhibitory factor (LIF) promotes BCC migration and invasion, elevates the expression of BC-derived CXCL1/2/3/8, and activates ERK1/2 signaling to further drive LIF expression in CAAs via NF-κB/STAT3 transcription. This evidence concerns the gene NFKB1 and breast cancer.